
Adaptix (formerly Radius Diagnostics Research, Inc.) is revolutionizing the way 3D images are obtained. Adaptix aims to help patients and health-care professionals to get the best possible diagnostic imaging information, wherever and whenever it is needed. For patients, this means a quicker and more accurate diagnosis at the bedside and less exposure to radiation; and for healthcare professionals it means saving costs and time. To do this, devices using Adaptix’ technology fire X-rays from different positions across a flat panel array of small X-ray emitters. Using an innovative reconstruction, a 3D Digital Tomosynthesis (DT) image set will be produced. These results provide more diagnostic accuracy than 2D imaging at a fraction of the dose received from a CT scan all in a mobile device that can be brought to the patient.
Graduated in 2014
Location: Oxford, United Kingdom
Contact:
www.adaptiximaging.com/contact
Graduated in 2014
Location: Oxford, United Kingdom
Contact:
www.adaptiximaging.com/contact
Graduated Companies
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete-AI
- Craytex
- CytoLumina
- DARTS Sciences
- Electronucleics
- EP Dynamics
- Ferrologix
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- Millibatt
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- SELFA
- Sixal
- Spectradyne Particle Analysis
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- Vivibaba
- Zenomics
- Back to Portfolio